Chronic Wound Care Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

The chronic wound care market encompasses dressings, bandages, wound therapy devices, skin substitutes, and topical agents used to manage non-healing wounds over weeks, months, or years. In 2025, the market is valued at approximately $16.15 billion and is projected to grow at a compound annual rate of around 5.8% through the early 2030s. Demand is concentrated in hospitals, specialty wound clinics, long-term care facilities, and increasingly in home health settings.

• •Estimated global value of $16.15 billion in 2025, with forecast growth near 5.8% CAGR.
• •Core product categories include advanced wound dressings, wound therapy devices, active wound care, and traditional dressings.
• •Key wound types addressed are diabetic foot ulcers, pressure ulcers, venous leg ulcers, and arterial ulcers.

The rising global prevalence of diabetes and obesity is the single largest demand driver, as both conditions are strongly associated with hard-to-heal foot and leg wounds. Aging populations in North America, Europe, and parts of Asia are adding to the patient base, since skin fragility, reduced mobility, and comorbidities all increase wound risk. Healthcare systems are also under pressure to reduce long hospital stays and amputation rates, which is accelerating adoption of advanced products that shorten healing time.

• •Diabetes prevalence continues to rise worldwide, fueling diabetic foot ulcer cases.
• •Growing elderly population increases incidence of pressure and venous ulcers.
• •Reimbursement reforms and emphasis on outpatient care are pushing adoption of advanced therapies.

By product, advanced wound dressings and wound therapy devices represent the largest and fastest-growing segments, while traditional gauze and bandages still hold meaningful share in cost-sensitive markets. By application, diabetic foot ulcers account for the leading share, followed by pressure ulcers and venous leg ulcers. Geographically, North America leads on the back of high diabetes rates, strong reimbursement, and early technology uptake, while Asia-Pacific is the fastest-growing region as healthcare access and chronic disease rates climb.

• •North America holds the largest regional share; Asia-Pacific is the fastest-growing market.
• •Diabetic foot ulcers are the dominant application segment, followed by pressure and venous ulcers.
• •Hospitals remain the largest end-use channel, but home healthcare is expanding quickly.

What are the recent trends and outlook?

The most visible trends are the shift toward bioactive and regenerative products such as skin substitutes, growth factor therapies, and cellular constructs, alongside wider use of negative pressure wound therapy in outpatient and home settings. Digital tools, including remote wound imaging and AI-assisted assessment, are beginning to support clinician decision-making and tele-wound care programs. Over the medium term, value-based care models are expected to reward products that demonstrably reduce healing time, infections, and amputations.

• •Bioactive dressings, skin substitutes, and growth factor therapies are gaining share over passive dressings.
• •Negative pressure wound therapy is being adapted for portable and home use.
• •Digital wound assessment and tele-wound care are emerging as growth areas within chronic wound management.